Skip to content

Effects of electroacupuncture in the treatment of patients with chronic urinary retention caused by lower motor neuron lesion: a prospective pilot study

Effects of electroacupuncture in the treatment of patients with neurogenic chronic urinary retention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020222
Enrollment
Unknown
Registered
2018-12-03
Start date
2017-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic urinary retention

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1. Had chronic urinary retention caused by lower motor neuron damage caused by injury of sacral plexus, cauda equina and sacral spinal cord, pelvic floor nerve lesion after pelvic surgery and peripheral neuropathy due to diabetes; 2. Aged more than 18 years; 3. Duration of disease was more than 3 months; 4. Had postvoid residual urine volume 300 mL or more and sensation of bladder; 5. CIC or transurethral bladder indwelling catheterization; 6. Had at least 4 weeks of treatment and had one record of assessment after treatment; 7. Signed informed consent and participated in the study voluntarily.

Exclusion criteria

Exclusion criteria: 1. Had urinary retention due to bladder outlet obstruction (bladder neck contracture, urethral stricture, prostate cancer, prostatic hyperplasia, etc.) 2. Had urinary system tumors or stones, urinary disorder due to lesions or injuries of thoracic spinal cord, cervical spinal cord and brain; 3. Detrusor underactivity caused by lesion of non-lower motor neuron; 4.Comorbidities of baldder and bowel dysfunction caused by lesion of thoracic cord, cervical cord and brain; 5. Had suprapubic cystostomy; 6. Had severe heart, liver, kidney, mental disorders or coagulation disorders; 7. Had been implanted a cardiac pacemaker, sacral nerve stimulation electrode, pudendal nerve stimulation electrode, or bladder stimulation electrode; 8. During pregnancy or in lactation.

Design outcomes

Primary

MeasureTime frame
The proportions of participants with a decline of 50% or more from baseline in the PVR volume after spontaneous urination;

Secondary

MeasureTime frame
The proportion of satisfactory spontaneous urination responders;The change from baseline of the postvoid residual urine volume after spontaneous urination;The proportion of patients with different degree of urination difficulty;The proportion of patients with catheterization;The proportion of patients with assisted bladder emptying;The proportion of patients with stool retention;The incidence of recurrent symptomatic urinary tract infection;The incidence of vesical calculus;The incidence of hydroureter;The incidence of hydronephrosis;

Countries

China

Contacts

Public ContactLiu Zhishun

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

liuzhishun@aliyun.com+86 13651016313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026